Skip to main content
SpringerLink
Log in

Classification of Cardiovascular Diseases: Epidemiology, Diagnosis, and Treatment

  • Reference work entry
  • First Online:
Handbook of Cardiovascular Behavioral Medicine

Abstract

This chapter reviews the main cardiovascular diseases (CVD) that are common in clinical practice and have received substantial attention from researchers in behavioral medicine and related disciplines. A concise overview is provided for hypertension, ischemic heart disease, cardiomyopathies, heart failure, cardiac arrhythmias, and stroke. For each CVD, we present information about disease characteristics, epidemiology, diagnostic tools, disease mechanisms, and treatment options. This chapter concludes with a general discussion of how these CVD features are relevant to research in cardiovascular behavioral medicine.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 549.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 329.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Adams KF Jr (2001) New epidemiologic perspectives concerning mild-to-moderate heart failure. Am J Med 110(Suppl 7A):6S–13S

    Article  PubMed  Google Scholar 

  2. American Heart Association (2003) Heart disease and stroke statistics – 2003 update

    Google Scholar 

  3. Anderson KM, Wilson PW, Odell PM, Kannel WB (1991) An updated coronary risk profile. A statement for health professionals. Circulation 83:356–362

    Article  PubMed  Google Scholar 

  4. Association TCCotNYH (1994) Revisions to classification of functional capacity and objective assessment of patients with diseases of the heart. Little, Brown & Co, Boston

    Google Scholar 

  5. Baessler A, Kwitek AE, Fischer M, Koehler M, Reinhard W, Erdmann J, Riegger G, Doering A, Schunkert H, Hengstenberg C (2006) Association of the ghrelin receptor gene region with left ventricular hypertrophy in the general population: results of the Monica/Kora Augsburg echocardiographic substudy. Hypertension 47:920–927

    Article  PubMed  Google Scholar 

  6. Benjamin EJ, Blaha MJ, Chiuve SE, Cushman M, Das SR, Deo R, de Ferranti SD, Floyd J, Fornage M, Gillespie C, Isasi CR, Jimenez MC, Jordan LC, Judd SE, Lackland D, Lichtman JH, Lisabeth L, Liu S, Longenecker CT, Mackey RH, Matsushita K, Mozaffarian D, Mussolino ME, Nasir K, Neumar RW, Palaniappan L, Pandey DK, Thiagarajan RR, Reeves MJ, Ritchey M, Rodriguez CJ, Roth GA, Rosamond WD, Sasson C, Towfighi A, Tsao CW, Turner MB, Virani SS, Voeks JH, Willey JZ, Wilkins JT, Wu JH, Alger HM, Wong SS, Muntner P (2017) Heart disease and stroke statistics-2017 update: a report from the American Heart Association. Circulation 135:e146–e603

    Article  PubMed  PubMed Central  Google Scholar 

  7. Berenson GS, McMahan C, Voors AW, Webber L, Srinivasan SR, Frank GC, Foster TA, Blonde CV (1980) Cardiovascular risk factors in children: the early natural history of atherosclerosis and essential hypertension. Oxford University Press, New York

    Google Scholar 

  8. Berenson GS, Wattigney WA, Tracy RE, Newman WP, Srinivasan SR, Webber LS, Dalferes ER, Strong JP (1992) Artherosclerosis of the aorta and coronary arteries and cardiovascular risk factors in persons aged 6 to 30 years and studied at necropsy (the Bogalusa Heart Study). Am J Cardiol 70:851–858

    Article  PubMed  Google Scholar 

  9. Berger JS, Jordan CO, Lloyd-Jones D, Blumenthal RS (2010) Screening for cardiovascular risk in asymptomatic patients. J Am Coll Cardiol 55:1169–1177

    Article  PubMed  Google Scholar 

  10. Black PH, Garbutt LD (2002) Stress, inflammation and cardiovascular disease. J Psychosom Res 52:1–23

    Article  PubMed  Google Scholar 

  11. Braunwald E (1997) Shattuck lecture – cardiovascular medicine at the turn of the millennium: triumphs, concerns, and opportunities. N Engl J Med 337:1360–1369

    Article  PubMed  Google Scholar 

  12. Brown DW, Giles WH, Croft JB (2000) Left ventricular hypertrophy as a predictor of coronary heart disease mortality and the effect of hypertension. Am Heart J 140:848–856

    Article  PubMed  Google Scholar 

  13. Burke GL, Voors AW, Shear CL, Webber LS, Smoak CG, Cresanta JL, Berenson GS (1987) Cardiovascular risk factors from birth to 7 years of age: the Bogalusa Heart Study. Blood pressure. Pediatrics 80:784–788

    Article  PubMed  Google Scholar 

  14. Busjahn A, Knoblauch H, Knoblauch M, Bohlender J, Menz M, Faulhaber HD, Becker A, Schuster H, Luft FC (1997) Angiotensin-converting enzyme and angiotensinogen gene polymorphisms, plasma levels, cardiac dimensions. A twin study. Hypertension 29:165–170

    Article  PubMed  Google Scholar 

  15. Callow AD (2006) Cardiovascular disease 2005 – the global picture. Vasc Pharmacol 45:302–307

    Article  Google Scholar 

  16. Campeau L (2002) The Canadian cardiovascular society grading of angina pectoris revisited 30 years later. Can J Cardiol 18:371–379

    PubMed  Google Scholar 

  17. Caplan LR, Gorelick PB, Hier DB (1986) Race, sex and occlusive cerebrovascular disease: a review. Stroke 17:648–655

    Article  PubMed  Google Scholar 

  18. Carson P, Ziesche S, Johnson G, Cohn JN (1999) Racial differences in response to therapy for heart failure: analysis of the vasodilator-heart failure trials. Vasodilator-heart failure trial study group. J Card Fail 5:178–187

    Article  PubMed  Google Scholar 

  19. Cavallotti C, Bruzzone P, Mancone M (2002) Catecholaminergic nerve fibers and β-adrenergic receptors in the human heart and coronary vessels. Heart Vessel 17(1):30–35

    Article  Google Scholar 

  20. Cheung BMY, Kumana CR (1998) Natriuretic peptides – relevance in cardiovascular disease. J Am Med Assoc 280:1983–1984. https://doi.org/10.1001/jama.280.23.1983

    Article  Google Scholar 

  21. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, Jones DW, Materson BJ, Oparil S, Wright JT Jr, Roccella EJ, the National High Blood Pressure Education Program Coordinating C (2003) Seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure. Hypertension 42:1206–1252. https://doi.org/10.1161/01.HYP.0000107251.49515.c2

    Article  PubMed  Google Scholar 

  22. Choksy P, Davis HC, Januzzi J, Thayer J, Harshfield G, Robinson VJ, Kapuku GK (2014) Brain natriuretic hormone predicts stress-induced alterations in diastolic function. Am J Med Sci 348:366–370

    Article  PubMed  PubMed Central  Google Scholar 

  23. Collaboration TERF (2012) C-reactive protein, fibrinogen, and cardiovascular disease prediction. N Engl J Med 367:1310–1320

    Article  Google Scholar 

  24. de Araújo GP, Ferreira J, Aguiar C, Seabra-Gomes R (2005) Timi, pursuit, and grace risk scores: sustained prognostic value and interaction with revascularization in NSTE-ACS. Eur Heart J 26:865–872

    Article  Google Scholar 

  25. de Ruijter W, Westendorp RGJ, Assendelft WJJ, den Elzen WPJ, de Craen AJM, le Cessie S, Gussekloo J (2009) Use of Framingham risk score and new biomarkers to predict cardiovascular mortality in older people: population based observational cohort study. BMJ. https://doi.org/10.1136/bmj.a3083.338

  26. de Simone G, Daniels SR, Devereux RB, Meyer RA, Roman MJ, de Divitiis O, Alderman MH (1992) Left ventricular mass and body size in normotensive children and adults: assessment of allometric relations and impact of overweight. J Am Coll Cardiol 20:1251–1260

    Article  PubMed  Google Scholar 

  27. DeFilippis AP, Young R, Carrubba CJ, McEvoy JW, Budoff MJ, Blumenthal RS, Kronmal RA, McClelland RL, Nasir K, Blaha MJ (2015) An analysis of calibration and discrimination among multiple cardiovascular risk scores in a modern multiethnic cohort. Ann Intern Med 162:266–275

    Article  PubMed  PubMed Central  Google Scholar 

  28. Dekkers C, Treiber FA, Kapuku G, Van Den Oord EJ, Snieder H (2002) Growth of left ventricular mass in African American and European American youth. Hypertension 39:943–951

    Article  PubMed  Google Scholar 

  29. Dimsdale JE (2008) Psychological stress and cardiovascular disease. J Am Coll Cardiol 51:1237–1246

    Article  PubMed  PubMed Central  Google Scholar 

  30. Dimsdale JE (2010) What does heart disease have to do with anxiety? J Am Coll Cardiol 56:47–48

    Article  PubMed  Google Scholar 

  31. Eckart RE, Scoville SL, Campbell CL, Shry EA, Stajduhar KC, Potter RN, Pearse LA, Virmani R (2004) Sudden death in young adults: a 25-year review of autopsies in military recruits. Ann Intern Med 141:829–834

    Article  PubMed  Google Scholar 

  32. Eisenmann JC (2004) Physical activity and cardiovascular disease risk factors in children and adolescents: an overview. Can J Cardiol 20:295–301

    PubMed  Google Scholar 

  33. Fitzmaurice C, Dicker D, Pain A, Hamavid H, Moradi-Lakeh M, MacIntyre MF, Allen C, Hansen G, Woodbrook R, Wolfe C (2015) The global burden of cancer 2013. JAMA Oncol 1:505–527

    Article  PubMed  Google Scholar 

  34. Fox KAA, Steg PG, Eagle KA, Goodman SG, Anderson FA Jr, Granger CB, Flather MD, Budaj A, Quill A, Gore JM, for the GI (2007) Decline in rates of death and heart failure in acute coronary syndromes, 1999–2006. JAMA 297:1892–1900. https://doi.org/10.1001/jama.297.17.1892

    Article  PubMed  Google Scholar 

  35. Franklin SS, Khan SA, Wong ND, Larson MG, Levy D (1999) Is pulse pressure useful in predicting risk for coronary heart disease? Circulation 100:354–360

    Article  PubMed  Google Scholar 

  36. Geny B, Charloux A, Lampert E, Lonsdorfer J, Haberey P, Piquard F (1998) Enhanced brain natriuretic peptide response to peak exercise in heart transplant recipients. J Appl Physiol 85:2270–2276

    Article  PubMed  Google Scholar 

  37. Go AS, Hylek EM, Phillips KA, Chang Y, Henault LE, Selby JV, Singer DE (2001) Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the anticoagulation and risk factors in atrial fibrillation (atria) study. JAMA 285:2370–2375

    Article  PubMed  Google Scholar 

  38. Gorelick PB, Caplan LR, Hier DB, Parker SL, Patel D (1984) Racial differences in the distribution of anterior circulation occlusive disease. Neurology 34:54–59

    Article  PubMed  Google Scholar 

  39. Grandi AM, Laurita E, Selva E, Piantanida E, Imperiale D, Giovanella L, Guasti L, Venco A (2004) Natriuretic peptides as markers of preclinical cardiac disease in obesity. Eur J Clin Investig 34:342–348

    Article  Google Scholar 

  40. Grundy SM, Balady GJ, Criqui MH, Fletcher G, Greenland P, Hiratzka LF, Houston-Miller N, Kris-Etherton P, Krumholz HM, LaRosa J, Ockene IS, Pearson TA, Reed J, Washington R, Smith SC Jr (1998) Primary prevention of coronary heart disease: guidance from Framingham: a statement for healthcare professionals from the Aha task force on risk reduction. Circulation 97:1876–1887

    Article  PubMed  Google Scholar 

  41. Hao G, Wang X, Treiber FA, Davis H, Leverett S, Su S, Kapuku G (2016) Growth of carotid intima-media thickness in black and white young adults. J Am Heart Assoc 5:e004147

    Article  PubMed  PubMed Central  Google Scholar 

  42. Harshfield GA, Pickering TG, Blank S, Lindahl C, Stroud L, Laragh JH (1984) Ambulatory blood pressure monitoring: recorders, applications, and analysis. In: Weber M, Drayer J (eds) Ambulatory blood pressure monitoring. Steinhopff-Verlag, Darmstadt, pp 1–7

    Google Scholar 

  43. Hashiba K, Tanigawa M, Fukatani M, Shimizu A, Konoe A, Kadena M, Mori M (1989) Electrophysiologic properties of atrial muscle in paroxysmal atrial fibrillation. Am J Cardiol 64:20J–23J

    Article  PubMed  Google Scholar 

  44. Hess DC, Wang S, Gross H, Nichols FT, Hall CE, Adams RJ (2006) Telestroke: extending stroke expertise into underserved areas. Lancet Neurol 5:275–278

    Article  PubMed  Google Scholar 

  45. Hippisley-Cox J, Coupland C, Vinogradova Y, Robson J, Brindle P (2008) Performance of the QRISK cardiovascular risk prediction algorithm in an independent UK sample of patients from general practice: a validation study. Heart 94:34–39

    Article  PubMed  Google Scholar 

  46. Hippisley-Cox J, Coupland C, Robson J, Brindle P (2010) Derivation, validation, and evaluation of a new QRISK model to estimate lifetime risk of cardiovascular disease: Cohort study using QResearch database. BMJ 341:c6624

    Article  PubMed  PubMed Central  Google Scholar 

  47. Ho JE, Enserro D, Brouwers FP, Kizer JR, Shah SJ, Psaty BM, Bartz TM, Santhanakrishnan R, Lee DS, Chan C (2016) Predicting heart failure with preserved and reduced ejection fraction. Circ Heart Fail 9:e003116

    Article  PubMed  Google Scholar 

  48. Hoffmann U, Ferencik M, Udelson JE, Picard MH, Truong QA, Patel MR, Huang M, Pencina MJ, Mark DB, Heitner JF (2017) Prognostic value of noninvasive cardiovascular testing in patients with stable chest pain: insights from the promise trial. Circulation. https://doi.org/10.1161/CIRCULATIONAHA.116.024360

  49. Horl WH (2005) Natriuretic peptides in acute and chronic kidney disease and during renal replacement therapy. J Investig Med 53:366–370

    Article  PubMed  Google Scholar 

  50. Iliescu C, Yusuf S, Auerbach L, Tong A, Vooletich M, Cortes J, Divakaran V, Lotlikar S, Woods M, Talpaz M (2005) Impact of angiotensin converting enzyme inhibitors and carvedilol on recovery of cardiac function in imatinib associated cardiomyopathy. J Card Fail 11:S104–S104

    Article  Google Scholar 

  51. Innes BA, McLaughlin MG, Kapuscinski MK, Jacob HJ, Harrap SB (1998) Independent genetic susceptibility to cardiac hypertrophy in inherited hypertension. Hypertension 31:741–746

    Article  PubMed  Google Scholar 

  52. James PA, Oparil S, Carter BL et al (2014) Evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the eighth joint national committee (JNC 8). JAMA 311:507–520

    Article  PubMed  Google Scholar 

  53. Jousilahti P, Vartiainen E, Tuomilehto J, Puska P (1999) Sex, age, cardiovascular risk factors, and coronary heart disease: a prospective follow-up study of 14 786 middle-aged men and women in Finland. Circulation 99:1165–1172

    Article  PubMed  Google Scholar 

  54. Julien J, Tranche C, Souchet T (2004) Left ventricular hypertrophy in hypertensive patients. Epidemiology and prognosis. Arch Mal Coeur Vaiss 97:221–227

    PubMed  Google Scholar 

  55. Juo SH, Di Tullio MR, Lin HF, Rundek T, Boden-Albala B, Homma S, Sacco RL (2005) Heritability of left ventricular mass and other morphologic variables in Caribbean hispanic subjects: the Northern Manhattan Family Study. J Am Coll Cardiol 46:735–737

    Article  PubMed  PubMed Central  Google Scholar 

  56. Kannel WB, Wilson P, Blair SN (1985) Epidemiological assessment of the role of physical activity and fitness in development of cardiovascular disease. Am Heart J 109:876–885

    Article  PubMed  Google Scholar 

  57. Kannel WB, Wolf PA, Castelli WP, D’Agostino RB (1987) Fibrinogen and risk of cardiovascular disease. The Framingham study. J Am Med Assoc 258:1183–1186

    Article  Google Scholar 

  58. Kapuku GK, Treiber FA, Davis HC, Harshfield GA, Cook BB, Mensah GA (1999) Hemodynamic function at rest, during acute stress, and in the field: predictors of cardiac structure and function 2 years later in youth. Hypertension 34:1026–1031

    Article  PubMed  Google Scholar 

  59. Kapuku GK, Ge D, Vemulapalli S, Harshfield GA, Treiber FA, Snieder H (2008) Change of genetic determinants of left ventricular structure in adolescence: longitudinal evidence from the Georgia cardiovascular twin study. Am J Hypertens 21:799–805

    Article  PubMed  Google Scholar 

  60. Kapuku GK, Davis H, Murdison K, Robinson V, Harshfield G (2012) Stress reduces diastolic function in youth. Psychosom Med 74:588

    Article  PubMed  PubMed Central  Google Scholar 

  61. Kastrati A, Hall D, Schömig A (2000) Long-term outcome after coronary stenting. Curr Control Trials Cardiovasc Med 1:48–54

    Article  PubMed  PubMed Central  Google Scholar 

  62. Kawai S, Kitabatake A, Tomoike H, Group TCS (2007) Guidelines for diagnosis of Takotsubo (ampulla) cardiomyopathy. Circ J 71:990–992

    Article  PubMed  Google Scholar 

  63. Kholaif N, Zheng Y, Jagasia P, Himmelmann A, James SK, Steg PG, Storey RF, Westerhout CM, Armstrong PW (2015) Baseline q waves and time from symptom onset to st-segment elevation myocardial infarction: insights from Plato on the influence of sex. Am J Med 128:914.e911–914.e919

    Article  Google Scholar 

  64. Khot UN, Khot MB, Bajzer CT, Sapp SK, Ohman EM, Brener SJ, Ellis SG, Lincoff AM, Topol EJ (2003) Prevalence of conventional risk factors in patients with coronary heart disease. JAMA 290:898–904. https://doi.org/10.1001/jama.290.7.898

    Article  PubMed  Google Scholar 

  65. Koglin J, Pehlivanli S, Schwaiblmair M, Vogeser M, Cremer P (2001) Role of brain natriuretic peptide in risk stratification of patients with congestive heart failure. J Am Coll Cardiol 38(7):1934–1941

    Article  PubMed  Google Scholar 

  66. Konoe A, Fukatani M, Tanigawa M, Isomoto S, Kadena M, Sakamoto T, Mori M, Shimizu A, Hashiba K (1992) Electrophysiological abnormalities of the atrial muscle in patients with manifest Wolff-Parkinson-White syndrome associated with paroxysmal atrial fibrillation. Pacing Clin Electrophysiol 15:1040–1052

    Article  PubMed  Google Scholar 

  67. Kop WJ (1999) Chronic and acute psychological risk factors for clinical manifestations of coronary artery disease. Psychosom Med 61:476–487

    Article  PubMed  Google Scholar 

  68. Kubo M, Hata J, Doi Y, Tanizaki Y, Iida M, Kiyohara Y (2008) Secular trends in the incidence of and risk factors for ischemic stroke and its subtypes in Japanese population. Circulation 118:2672–2678. https://doi.org/10.1161/CIRCULATIONAHA.107.743211

    Article  PubMed  Google Scholar 

  69. Kupari M, Hautanen A, Lankinen L, Koskinen P, Virolainen J, Nikkila H, White PC (1998) Associations between human aldosterone synthase (cyp11b2) gene polymorphisms and left ventricular size, mass, and function. Circulation 97:569–575

    Article  PubMed  Google Scholar 

  70. Law M, Morris J, Wald N (2009) Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies. BMJ 338:b1665

    Article  PubMed  PubMed Central  Google Scholar 

  71. Maron BJ, Doerer JJ, Haas TS, Tierney DM, Mueller FO (2009) Sudden deaths in young competitive athletes. Circulation 119:1085–1092

    Article  PubMed  Google Scholar 

  72. Mozaffarian D, Benjamin EJ, Go AS, Arnett DK, Blaha MJ, Cushman M, Das SR, de Ferranti S, Després J-P, Fullerton HJ, Howard VJ, Huffman MD, Isasi CR, Jiménez MC, Judd SE, Kissela BM, Lichtman JH, Lisabeth LD, Liu S, Mackey RH, Magid DJ, McGuire DK, Mohler ER, Moy CS, Muntner P, Mussolino ME, Nasir K, Neumar RW, Nichol G, Palaniappan L, Pandey DK, Reeves MJ, Rodriguez CJ, Rosamond W, Sorlie PD, Stein J, Towfighi A, Turan TN, Virani SS, Woo D, Yeh RW, Turner MB (2016) Executive summary: heart disease and stroke statistics – 2016 update. A Report From the American Heart Association. Circulation 133:447–454

    Article  PubMed  Google Scholar 

  73. National Center for Health S. Health, United States (2015) Health, United States, 2014: with special feature on adults aged 55–64. National Center for Health Statistics (US), Hyattsville

    Google Scholar 

  74. National High Blood Pressure Education Program Working Group on High Blood Pressure in Children and A (2004) The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents. Pediatrics 114:555–576. https://doi.org/10.1542/peds.114.2.S2.555

    Article  Google Scholar 

  75. Oparil S, Oberman A (1999) Nontraditional cardiovascular risk factors. Am J Med Sci 317:193–207

    Article  PubMed  Google Scholar 

  76. Paffenbarger RS Jr, Blair SN, Lee IM (2001) A history of physical activity, cardiovascular health and longevity: the scientific contributions of Jeremy N Morris, DSC, DPH, FRCP. Int J Epidemiol 30:1184–1192

    Article  PubMed  Google Scholar 

  77. Page RL, Joglar JA, Caldwell MA, Calkins H, Conti JB, Deal BJ, Estes NAM, Field ME, Goldberger ZD, Hammill SC, Indik JH, Lindsay BD, Olshansky B, Russo AM, Shen W-K, Tracy CM, Al-Khatib SM (2015) 2015 ACC/AHA/HRS guideline for the management of adult patients with supraventricular tachycardia. A report of the American College of Cardiology/American Heart Association Task Force on clinical practice guidelines and the heart rhythm society

    Google Scholar 

  78. Perk J, De Backer G, Gohlke H, Graham I, Reiner Ž, Verschuren WMM, Albus C, Benlian P, Boysen G, Cifkova R, Deaton C, Ebrahim S, Fisher M, Germano G, Hobbs R, Hoes A, Karadeniz S, Mezzani A, Prescott E, Ryden L, Scherer M, Syvänne M, Op Reimer WJ, Vrints C, Wood D, Zamorano JL, Zannad F (2012) European guidelines on cardiovascular disease prevention in clinical practice (version 2012): the fifth joint task force of the European Society of Cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of nine societies and by invited experts). Eur Heart J 223(1):1–68

    Google Scholar 

  79. Pierce GL, Pajaniappan M, DiPietro A, Darracott-Woei-A-Sack K, Kapuku GK (2016) Abnormal central pulsatile hemodynamics in adolescents with obesity novelty and significance. Hypertension 68:1200–1207

    Article  PubMed  Google Scholar 

  80. Poch E, Gonzalez D, Gomez-Angelats E, Enjuto M, Pare JC, Rivera F, de La Sierra A (2000) G-protein beta(3) subunit gene variant and left ventricular hypertrophy in essential hypertension. Hypertension 35:214–218

    Article  PubMed  Google Scholar 

  81. Post WS, Larson MG, Myers RH, Galderisi M, Levy D (1997) Heritability of left ventricular mass the Framingham Heart Study. Hypertension 30:1025–1028

    Article  PubMed  Google Scholar 

  82. Priori SG, Blomström-Lundqvist C, Mazzanti A, Blom N, Borggrefe M, Camm J, Elliott PM, Fitzsimons D, Hatala R, Hindricks G, Kirchhof P, Kjeldsen K, Kuck K-H, Hernandez-Madrid A, Nikolaou N, Norekvål TM, Spaulding C, Van Veldhuisen DJ, Kolh P, Lip GYH, Agewall S, Barón-Esquivias G, Boriani G, Budts W, Bueno H, Capodanno D, Carerj S, Crespo-Leiro MG, Czerny M, Deaton C, Dobrev D, Erol Ç, Galderisi M, Gorenek B, Kriebel T, Lambiase P, Lancellotti P, Lane DA, Lang I, Manolis AJ, Morais J, Moreno J, Piepoli MF, Rutten FH, Sredniawa B, Zamorano JL, Zannad F (2015) 2015 ESC guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death the task force for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death of the European Society of Cardiology (ESC) endorsed by: Association for European Pediatric and Congenital Cardiology (AEPC). Eur Heart J 36:2793–2867

    Article  PubMed  Google Scholar 

  83. Rahimi K, Emdin CA, MacMahon S (2015) The epidemiology of blood pressure and its worldwide management. Circ Res 116:925–936

    Article  PubMed  Google Scholar 

  84. Ridker PM, Hennekens CH, Buring JE, Rifai N (2000) C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med 342:836–843

    Article  PubMed  Google Scholar 

  85. Ridker PM, Buring JE, Rifai N, Cook NR (2007) Development and validation of improved algorithms for the assessment of global cardiovascular risk in women: the Reynolds risk score. JAMA 297:611–619

    Article  PubMed  Google Scholar 

  86. Roger VL, Go AS, Lloyd-Jones DM, Adams RJ, Berry JD, Brown TM, Carnethon MR, Dai S, de Simone G, Ford ES, Fox CS, Fullerton HJ, Gillespie C, Greenlund KJ, Hailpern SM, Heit JA, Ho PM, Howard VJ, Kissela BM, Kittner SJ, Lackland DT, Lichtman JH, Lisabeth LD, Makuc DM, Marcus GM, Marelli A, Matchar DB, McDermott MM, Meigs JB, Moy CS, Mozaffarian D, Mussolino ME, Nichol G, Paynter NP, Rosamond WD, Sorlie PD, Stafford RS, Turan TN, Turner MB, Wong ND, Wylie-Rosett J (2011) Heart disease and stroke statistics – 2011 update: a report from the American heart association. Circulation 123:e18–e209

    Article  PubMed  Google Scholar 

  87. Rosamond W, Flegal K, Furie K, Go A, Greenlund K, Haase N, Hailpern SM, Ho M, Howard V, Kissela B, Kittner S, Lloyd-Jones D, McDermott M, Meigs J, Moy C, Nichol G, O’Donnell C, Roger V, Sorlie P, Steinberger J, Thom T, Wilson M, Hong Y (2008) Heart disease and stroke statistics – 2008 update: a report from the American heart association statistics committee and stroke statistics subcommittee. Circulation 117:e25–e146

    PubMed  Google Scholar 

  88. Roth GA, Huffman MD, Moran AE, Feigin V, Mensah GA, Naghavi M, Murray CJ (2015) Global and regional patterns in cardiovascular mortality from 1990 to 2013. Circulation 132:1667–1678

    Article  PubMed  Google Scholar 

  89. Rutan GH, Kuller LH, Neaton JD, Wentworth DN, McDonald RH, Smith WM (1988) Mortality associated with diastolic hypertension and isolated systolic hypertension among men screened for the multiple risk factor intervention trial. Circulation 77:504–514

    Article  PubMed  Google Scholar 

  90. Sagnella GA (2001) Atrial natriuretic peptide mimetics and vasopeptidase inhibitors. Cardiovasc Res 51:416–428

    Article  PubMed  Google Scholar 

  91. Scarabin PY, Aillaud MF, Amouyel P, Evans A, Luc G, Ferrieres J, Arveiler D, Juhan-Vague I (1998) Associations of fibrinogen, factor vii and pai-1 with baseline findings among 10,500 male participants in a prospective study of myocardial infarction – the prime study. Prospective epidemiological study of myocardial infarction. Thromb Haemost 80:749–756

    Article  PubMed  Google Scholar 

  92. Schmitt M, Qasem A, McEniery C, Wilkinson IB, Tatarinoff V, Noble K, Klemes J, Payne N, Frenneaux MP, Cockcroft J, Avolio A (2004) Role of natriuretic peptides in regulation of conduit artery distensibility. Am J Physiol Heart Circ Physiol 287:H1167–H1171

    Article  PubMed  Google Scholar 

  93. Schunkert H, Hense HW, Holmer SR, Stender M, Perz S, Keil U, Lorell BH, Gunter GAJ (1994) Association between a deletion polymorphism of the angiotensin-converting-enzyme and left ventricular hypertrophy. N Engl J Med 330:1634–1638

    Article  PubMed  Google Scholar 

  94. Shimizu A, Fukatani M, Tanigawa M, Mori M, Hashiba K (1989) Intra-atrial conduction delay and fragmented atrial activity in patients with paroxysmal atrial fibrillation. Jpn Circ J 53:1023–1030

    Article  PubMed  Google Scholar 

  95. Shukla A, Yusuf SW, Daher I, Lenihan D, Durand J (2008) High mortality rates are associated with withdrawal of beta blockers and ace inhibitors in chemotherapy-induced heart failure

    Google Scholar 

  96. Sikri N, Bardia A (2007) A history of streptokinase use in acute myocardial infarction. Tex Heart Inst J 34:318–327

    PubMed  PubMed Central  Google Scholar 

  97. Spodick DH (1992) Normal sinus heart rate: sinus tachycardia and sinus bradycardia redefined. Am Heart J 124:1119–1121

    Article  PubMed  Google Scholar 

  98. van Montfort E, Denollet J, Vermunt JK, Widdershoven J, Kupper N (2017) The tense, the hostile and the distressed: multidimensional psychosocial risk profiles based on the esc interview in coronary artery disease patients – the thoresci study. Gen Hosp Psychiatry 47:103–111

    Article  PubMed  Google Scholar 

  99. Verhaaren HA, Schieken RM, Mosteller M, Hewitt JK, Eaves LJ, Nance WE (1991) Bivariate genetic analysis of left ventricular mass and weight in pubertal twins (the medical college of Virginia twin study). Am J Cardiol 68:661–668

    Article  PubMed  Google Scholar 

  100. Vos T, Allen C, Arora M, Barber RM, Bhutta ZA, Brown A, Carter A, Casey DC, Charlson FJ, Chen AZ (2016) Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990–2015: a systematic analysis for the global burden of disease study 2015. Lancet 388:1545

    Article  Google Scholar 

  101. Wachtell K, Bella JN, Liebson PR, Gerdts E, Dahlof B, Aalto T, Roman MJ, Papademetriou V, Ibsen H, Rokkedal J, Devereux RB (2000) Impact of different partition values on prevalences of left ventricular hypertrophy and concentric geometry in a large hypertensive population: the life study. Hypertension 35:6–12

    Article  PubMed  Google Scholar 

  102. Wang S, Gross H, Lee SB, Pardue C, Waller J, Nichols FT, Adams RJ, Hess DC (2004) Remote evaluation of acute ischemic stroke in rural community hospitals in Georgia. Stroke 35:1763–1768

    Article  PubMed  Google Scholar 

  103. Yancy CW, Jessup M, Bozkurt B, Butler J, Casey DE, Colvin MM, Drazner MH, Filippatos GS, Fonarow GC, Givertz MM (2017) 2017 ACC/AHA/HFSA focused update of the 2013 ACCF/AHA guideline for the management of heart failure: a report of the American college of cardiology/American Heart Association task force on clinical practice guidelines and the Heart Failure Society of America. J Am Coll Cardiol 70(6):776–803

    Google Scholar 

  104. Yano K, Hirata M, Matsumoto Y, Hano O, Mori M, Ahmed R, Mitsuoka T, Hashiba K (1989) Effects of chronic hypokalemia on ventricular vulnerability during acute myocardial ischemia in the dog. Jpn Heart J 30:205–217

    Article  PubMed  Google Scholar 

  105. Zellner C, Protter AA, Ko E, Pothireddy MR, DeMarco T, Hutchison SJ, Chou TM, Chatterjee K, Sudhir K (1999) Coronary vasodilator effects of BNP: mechanisms of action in coronary conductance and resistance arteries. Am J Physiol 276:H1049–H1057

    PubMed  Google Scholar 

  106. Zimetbaum P (2012) Antiarrhythmic drug therapy for atrial fibrillation. Circulation 125:381–389

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pediatrics, Medicine, and Population Health Sciences, Augusta University, Medical College of Georgia, Georgia Prevention Institute, Augusta, GA, USA

    Gaston K. Kapuku

  2. Department of Medical and Clinical Psychology, Tilburg University, Tilburg, The Netherlands

    Willem J. Kop

Authors
  1. Gaston K. Kapuku
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Willem J. Kop
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Gaston K. Kapuku .

Editor information

Editors and Affiliations

  1. Department of Psychology, University of Maryland, Baltimore County, Baltimore, MD, USA

    Shari R. Waldstein

  2. Department of Medical and Clinical Psychology, Tilburg University, Tilburg, The Netherlands

    Willem J. Kop

  3. Department of Psychiatry and Behavioral Sciences, Duke University Medical Center, Durham, NC, USA

    Edward C. Suarez

  4. Department of Psychiatry and Behavioral Sciences, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA

    William R. Lovallo

  5. Division of Gerontology Geriatrics and Palliative Medicine Department of Medicine, University of Maryland School of Medicine, Baltimore, MD, USA

    Leslie I. Katzel

Rights and permissions

Reprints and permissions

Copyright information

© 2022 The Author(s), under exclusive license to Springer Science+Business Media, LLC, part of Springer Nature

About this entry

Check for updates. Verify currency and authenticity via CrossMark

Cite this entry

Kapuku, G.K., Kop, W.J. (2022). Classification of Cardiovascular Diseases: Epidemiology, Diagnosis, and Treatment. In: Waldstein, S.R., Kop, W.J., Suarez, E.C., Lovallo, W.R., Katzel, L.I. (eds) Handbook of Cardiovascular Behavioral Medicine. Springer, New York, NY. https://doi.org/10.1007/978-0-387-85960-6_3

Download citation

Publish with us

Policies and ethics

Search

Navigation